ON DEMAND WEBINAR
Overview
The workshop and its complementary activities will focus on the real-world application of evidence, guidelines and management systems, to improve the diagnosis, treatment and support of patients seeking MAR. After reviewing the evidence, delegates will evaluate markers of infertility and select responses they perceive important to specific situations. They will also learn about the value of expert opinion and debate in relation to current research and evidence-based medicine. Measures of success will be discussed that support patient engagement, development of individualized treatment plans and support best practice. The ultimate goal of the workshop is for fertility nurses and midwives to promote patient-centred care, through the delivery of holistic, advanced fertility nursing/midwifery practice.
Demand for MAR is increasing, globally, in part due to the continued worldwide decline in female and male fertility and advancing female age at first pregnancy. While advances in MAR have created scope and diversity in treatment options, novel processes, both evidence and non-evidence based, have also increased patient expectations. Processes or treatment ‘add-ons’ lacking such evidence include: medications, investigations, equipment, alternative therapies, laboratory procedures and surgical interventions, all of which aim to enhance pregnancy and live birth rates in addition to reducing the risk of miscarriage. It is therefore essential that nurses and midwives understand the clinical and physiological rationale for treatment ‘add-ons’, including the intended effects, risks and side-effects. According to the Human Fertilisation & Embryology Authority (HFEA), where there is no evidence to support safety and efficacy of treatment ‘add-ons’, they should only be offered in a research setting with full ethics approval. Nevertheless, due to limited global government funding of fertility services, the private sector has experienced increased demand, which has influenced marketing, driven online patient and professional communication and social media, subsequently leading to increased patient expectations of fertility services.
This webinar will therefore enhance our understanding of treatment ‘add-on’s’, thus enabling effective communication and informed decision-making.
Overall Learning Objectives
After participating in this workshop and related activities, delegates will be able to:
- ● Enhance their understanding of the clinical and physiological rationale for treatment ‘add-ons’, including the intended effects, risks and side-effects
- ● Enhance their understanding of best practice recommendations
- ● Enable effective communication and informed decision making when consenting to treatment ‘add-ons’
Target Audience
Nurses and midwives working in fertility or early pregnancy settings who wish to advance their professional and clinical practice; update their knowledge of advanced, evidence and non-evidence-based treatment ‘add-ons’ and improve their understanding of the clinical and physiological justification when informing and consenting patients in the process of medically assisted reproduction (MAR).
Accreditation
An application for this online workshop has been made to the Royal College of Nursing (RCN) – Accreditation applies only to the educational content and not to any product. The RCN cannot confirm the competence of any practitioner.
The Nurses’ Virtual Workshop in medically assisted reproduction: Treatment add-ons’ – where is the evidence and how do we manage patient expectations?, Online, Italy 21/11/2025 – 21/11/2025, has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME®) with 2.5 European CME credits (ECMEC®s).
Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity.” “Through an agreement between the Union Européenne des Médecins Spécialistes and the American Medical Association, physicians may convert EACCME® credits to an equivalent number of AMA PRA Category 1 CreditsTM. Information on the process to convert EACCME® credit to AMA credit can be found at https://edhub.ama-assn.org/pages/applications . “Live educational activities, occurring outside of Canada, recognised by the UEMS-EACCME® for ECMEC®s are deemed to be Accredited Group Learning Activities (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada.”
Information regarding the conversion of EACCME® credits:
Credit will be converted based on one (1) hour of participation equalling one credit for all activities. Physicians wishing to convert EACCME® credits to AMA PRA Category 1 Credit™ will be required to access the AMA website at https://edhub.amaassn.org/pages/applications to obtain the necessary paperwork and instructions. Physicians and other health care professionals will be required to pay a processing fee to the AMA. For other countries, please contact the relevant national/regional accreditation authority.
The programme has been developed in partnership with
Med.E.A. is in partnership with
Algerian Society of Reproductive Medicine (SAMERE)
Association of Reproductive Medicine and Surgery (ARMS)
British Fertility Society (BFS)
Brazilian Society of Human Reproduction (SBRH)
Italian Society of Embryology, Reproduction and Research (SIERR)
Italian Society of Fertility and Sterility (SIFES)
Italian Society of Gynecology and Obstetrics (SIGO Federation)
Portuguese Society of Reproductive Medicine (SPMR)
Turkish Society of Reproductive Medicine (TSRM)
Nurses’ Virtual Workshop in medically assisted reproduction: Treatment add-ons’ – where is the evidence and how do we manage patient expectations?
21 November 2025
Chairs
Faculty
International Committee
Paola Anserini
Ospedale Policlinico San Martino
Genova, Italy
Baris Ata
Koc University Istanbul
Dubai, United Arab Emirates
Kevin McEleny
Gateshead and the Freeman Hospital
Newcastle, UK
Paula Navarro
University of Sao Paulo,
Sao Paulo, Brazil
Scientific Programme
Agenda
21 November 2025
13.00-15.30 CET Central Europe Time
13.00-15.30 CET Central Europe Time
13.00 MedEA Medical Education Academy welcome and introduction
Sandro Esteves, Brazil
13.05 Workshop introduction
Valerie Peddie, Scotland, UK
13.10 L1: Endometrial Receptivity and key components of immunology in fertility treatment: delivering safe, integrated, good-quality care
Valerie Peddie, Scotland, UK
13.30 L2: Pre-implantation Genetic Testing for Aneuploidy (PGT-A)
Yusuf Beebeejaun, UK
13.50 Q&A session
14.10 L3: Good Practice Recommendations on Add-ons: managing patient expectations
Joyce Harper, UK
14.30 L4: Supplements ~ impact of the Global Fertility Supplement Market
Marina Viana, Brazil
14.50 Q&A session
15.20 Conclusion
Sandro Esteves, Brazil
